At a conference in New England, Rohan Simon, an associate director at the UAE’s first contract research organization, discussed the […]

GSK, a pharmaceutical company, is spending $300 million to buy a special type of drug from Chimagen Biosciences, a company

The FDA has given special status to a new treatment called MDL-101 by Modalis Therapeutics for a rare muscle disorder

Pfizer recently reported strong earnings for the third quarter, surpassing Wall Street expectations. As a result, the company has increased

Ultra-processed foods (UPFs) are linked to health issues like obesity, diabetes, heart disease, and some cancers. In India, obesity rates

The UK government and its drug regulator have issued a warning about the misuse of certain weight-loss medications. These drugs,

AbbVie has agreed to buy Aliada Therapeutics for $1.4 billion. This deal includes Aliada’s main product, ALIA-1758, which is being

Pfizer and the American Cancer Society (ACS) have teamed up with actor Patrick Dempsey to spotlight healthcare access issues that

A recent trial found that nearly 60% of patients with a rare condition called eosinophilic granulomatosis with polyangiitis (EGPA) went

Parabilis Medicines, previously known as FogPharma, is a biotech company that has changed its name to better reflect its mission.